MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes

Molecular and Cellular Biology

Volumn 29, Issue 8, 2009, Pages 2193-2204

  Ikeda, Sadakatsu ^a,b,c   He, Aibin ^a,b,c   Kong, Sek Won ^a,b,c   Lu, Jun ^a   Bejar, Rafael ^b   Bodyak, Natalya ^a,d   Lee, Kyu Ho ^a,b,c,g   Ma, Qing ^a,b,c   Kang, Peter M ^a,d   Golub, Todd R ^a,e,f   Pu, William T ^a,b,c,d,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f HARVARD STEM CELL INSTITUTE   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALMODULIN; MICRORNA; MICRORNA 1; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HEART FAILURE; HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; CALMODULIN; CARDIOMEGALY; CELLS, CULTURED; DOWN-REGULATION; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HEART FAILURE; HYPERTROPHY; MICE; MICRORNAS; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS;

RATTUS;

EID: 64649094112     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01222-08     Document Type: Article

References (46)

1. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
2. Baskerville, S., and D. P. Bartel. 2005. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241-247.
3. Betel, D., M. Wilson, A. Gabow, D. S. Marks, and C. Sander. 2008. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36: D149-D153.
4. Bisping, E., S. Ikeda, S. W. Kong, O. Tarnavski, N. Bodyak, J. R. McMullen, S. Rajagopal, J. K. Son, Q. Ma, Z. Springer, P. M. Kang, S. Izumo, and W. T. Pu. 2006. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc. Natl. Acad. Sci. USA 103:14471-14476.
5. Bodyak, N., P. M. Kang, M. Hiromura, I. Sulijoadikusumo, N. Horikoshi, K. Khrapko, and A. Usheva. 2002. Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res. 30:3788-3794.
6. Caré, A., D. Catalucci, F. Felicetti, D. Bond, A. Addario, P. Gallo, M. L. Bang, P. Segnalini, Y. Gu, N. D. Dalton, L. Elia, M. V. Latronico, M. Høydal, C. Autore, M. A. Russo, G. W. Dorn II, O. Ellingsen, P. Ruiz-Lozano, K. L. Peterson, C. M. Croce, C. Peschle, and G. Condorelli. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13:613-618.
7. Chen, J. F., E. M. Mandel, J. M. Thomson, Q. Wu, T. E. Callis, S. M. Hammond, F. L. Conlon, and D. Z. Wang. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38:228-233.
8. Cheng, Y., R. Ji, J. Yue, J. Yang, X. Liu, H. Chen, D. B. Dean, and C. Zhang. 2007. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am. J. Pathol. 170:1831-1840.
9. Farh, K. K., A. Grimson, C. Jan, B. P. Lewis, W. K. Johnston, L. P. Lim, C. B. Burge, and D. P. Bartel. 2005. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310:1817-1821.
10. Habara-Ohkubo, A. 1996. Differentiation of beating cardiac muscle cells from a derivative of P19 embryonal carcinoma cells. Cell Struct. Funct. 21:101-110.
11. He, A., L. Zhu, N. Gupta, Y. Chang, and F. Fang. 2007. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 21:2785-2794.
12. Ikeda, S., S. W. Kong, J. Lu, E. Bisping, H. Zhang, P. D. Allen, T. R. Golub, B. Pieske, and W. T. Pu. 2007. Altered microRNA expression in human heart disease. Physiol. Genomics 31:367-373.
13. Izumo, S., B. Nadal-Ginard, and V. Mahdavi. 1988. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA 85:339-343.
14. John, B., A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks. 2004. Human MicroRNA targets. PLoS Biol. 2:e363.
15. Jongeneel, C. V., M. Delorenzi, C. Iseli, D. Zhou, C. D. Haudenschild, I. Khrebtukova, D. Kuznetsov, B. J. Stevenson, R. L. Strausberg, A. J. Simpson, and T. J. Vasicek. 2005. An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res. 15:1007-1014.
16. Katz, A. M. 1995. The cardiomyopathy of overload: an unnatural growth response. Eur. Heart J. 16(Suppl. O):110-114.
17. Krek, A., D. Grun, M. N. Poy, R. Wolf, L. Rosenberg, E. J. Epstein, P. MacMenamin, I. da Piedade, K. C. Gunsalus, M. Stoffel, and N. Rajewsky. 2005. Combinatorial microRNA target predictions. Nat. Genet. 37:495-500.
18. Krutzfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Mano-haran, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs.' Nature 438:685-689.
19. Lagos-Quintana, M., R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739.
20. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
21. Liang, Q., L. J. De Windt, S. A. Witt, T. R. Kimball, B. E. Markham, and J. D. Molkentin. 2001. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 276: 30245-30253.
22. Lim, H. W., L. J. De Windt, J. Mante, T. R. Kimball, S. A. Witt, M. A. Sussman, and J. D. Molkentin. 2000. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J. Mol. Cell. Cardiol. 32:697-709.
23. Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A, Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, and T. R. Golub. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
24. McKinsey, T. A., and E. N. Olson. 2005. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Investig. 115:538-546.
25. Molkentin, J. D., J. R. Lu, C. L. Antos, B. Markham, J. Richardson, J. Robbins, S. R. Grant, and E. N. Olson. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228.
26. Morin, S., F. Charron, L. Robitaille, and M. Nemer. 2000. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19:2046-2055.
27. Obata, K., K. Nagata, M. Iwase, M. Odashima, T. Nagasaka, H. Izawa, T. Murohara, Y. Yamada, and M. Yokota. 2005. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway. Biochem. Biophys. Res. Commun. 338:1299-1305.
28. Oka, T., M. Maillet, A. J. Watt, R. J. Schwartz, B. J. Aronow, S. A. Duncan, and J. D. Molkentin. 2006. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 98:837-845.
29. Passier, R., H. Zeng, N. Frey, F. J. Naya, R. L. Nicol, T. A, McKinsey, P. Overbeek, J. A. Richardson, S. R. Grant, and E. N. Olson. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Investig. 105:1395-1406.
30. Pu, W. T., Q. Ma, and S. Izumo. 2003. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circ. Res. 92:725-731.
31. Sayed, D., C. Hong, I. Y. Chen, J. Lypowy, and M. Abdellatif. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100:416-424.
32. Simon, D. J., J. M. Madison, A. L. Conery, K. L. Thompson-Peer, M. Soskis, G. B. Ruvkun, J. M. Kaplan, and J. K. Kim. 2008. The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 133:903-915.
33. Smyth, G. K., and T. Speed. 2003. Normalization of cDNA microarray data. Methods 31:265-273.
34. Storey, J. D., and R. Tibshirani. 2003. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100:9440-9445.
35. Thum, T., P. Galuppo, C. Wolf, J. Fiedler, S. Kneitz, L. W. van Laake, P. A. Doevendans, C. L. Mummery, J. Borlak, A. Haverich, C. Gross, S. Engelhardt, G. Ertl, and J. Bauersachs. 2007. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116: 258-267.
36. Toutenhoofd, S. L., and E. E. Strehler. 2000. The calmodulin multigene family as a unique case of genetic redundancy: multiple levels of regulation to provide spatial and temporal control of calmodulin pools? Cell Calcium 28:83-96.
37. van Oort, R. J., E. van Rooij, M. Bourajjaj, J. Schimmel, M. A. Jansen, R. van der Nagel, P. A. Doevendans, M. D. Schneider, C. J. van Echteld, and L. J. De Windt. 2006. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 114:298-308.
38. van Rooij, E., N. Liu, and E. N. Olson. 2008. MicroRNAs flex their muscles. Trends Genet. 24:159-166.
39. van Rooij, E., L. B. Sutherland, N. Liu, A, H. Williams, J. McAnally, R. D. Gerard, J. A. Richardson, and E. N. Olson. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 103:18255-18260.
40. Wilkins, B. J., Y. S. Dai, O. F. Bueno, S. A, Parsons, J. Xu, D. M. Plank, F. Jones, T. R. Kimball, and J. D. Molkentin. 2004. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94:110-118.
41. Wu, X., and D. M. Bers. 2007. Free and bound intracellular calmodulin measurements in cardiac myocytes. Cell Calcium 41:353-364.
42. Xu, J., N. L. Gong, I. Bodi, B. J. Aronow, P. H. Backx, and J. D. Molkentin. 2006. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281:9152-9162.
43. Yang, B., H. Lin, J. Xiao, Y. Lu, X. Luo, B. Li, Y. Zhang, C. Xu, Y. Bai, H. Wang, G. Chen, and Z. Wang. 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13:486-491.
44. Zhang, C. L., T. A, McKinsey, S. Chang, C. L. Antos, J. A, Hill, and E. N. Olson. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479-488.
45. Zhao, Y., J. F. Ransom, A. Li, V. Vedantham, M. von Drehle, A. N. Muth, T. Tsuchihashi, M. T. McManus, R. J. Schwartz, and D. Srivastava. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317.
46. Zhao, Y., E. Samal, and D. Srivastava. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220.